The Claim
Approximately 22 peptide-based therapeutics exhibiting antibacterial and antifungal activity are currently undergoing various phases of clinical trials, indicating active development in this therapeutic category.
What the research says
Roughly balanced
Support and challenge are close. The picture may shift as more studies come in.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
Scientists are developing about 22 special protein pieces (called peptides) that can fight bacteria and fungi, and all of them are being tested in human clinical trials right now.
See the scientific wording
Approximately 22 peptide therapeutics with antibacterial and antifungal activity are currently undergoing various phases of clinical trials, demonstrating active development in this therapeutic class.
What the research says
1 studyStudy: FDA-Approved Antibacterials and Echinocandins
The study directly confirms what the claim says - it states that about 22 peptide drugs with antibacterial and antifungal properties are currently in clinical trials, which matches the claim exactly.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.